Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001927037 | SCV002206461 | likely benign | Epilepsy, childhood absence, susceptibility to, 1; Epilepsy, childhood absence, susceptibility to, 5 | 2022-07-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002423067 | SCV002681771 | uncertain significance | Inborn genetic diseases | 2019-07-30 | criteria provided, single submitter | clinical testing | The c.81-5C>G intronic variant results from a C to G substitution 5 nucleotides upstream from coding exon 2 in the GABRB3 gene. This nucleotide position is not well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to weaken the efficiency of the native splice acceptor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |